PK/PD Study of YZJ-1139
- First Posted Date
- 2024-11-12
- Last Posted Date
- 2024-11-12
- Target Recruit Count
- 20
- Registration Number
- NCT06685341
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Capital Medical University, Beijing, China
A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-11-08
- Target Recruit Count
- 179
- Registration Number
- NCT06680466
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets
- Conditions
- Interventions
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-11-08
- Target Recruit Count
- 24
- Registration Number
- NCT06680531
- Locations
- 🇨🇳
The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder
- Conditions
- Interventions
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-11-08
- Target Recruit Count
- 300
- Registration Number
- NCT06680505
- Locations
- 🇨🇳
Beijing HuiLongGuan Hospital, Beijing, China
🇨🇳Peking University People's Hospital, Beijing, China
🇨🇳Xiangya Hospital, Central South University, Changsha, China
A Phase 1 Study of YZJ-4729 Tartrate Injection in Healthy Chinese Subjects
- Conditions
- Interventions
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-11-08
- Target Recruit Count
- 66
- Registration Number
- NCT06681493
- Locations
- 🇨🇳
Xiangya Third Hospital, Central South University, Changsha, China
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2024-11-05
- Target Recruit Count
- 104
- Registration Number
- NCT06673927
- Locations
- 🇨🇳
Beijing Ditan Hospital Capital Medical University, Beijing, China
A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Target Recruit Count
- 27
- Registration Number
- NCT06671470
- Locations
- 🇨🇳
Shulan (Hangzhou) Hospital, Huangzhou, China
Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Mild, Moderate and Normal Hepatic Impairment
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Target Recruit Count
- 24
- Registration Number
- NCT06671509
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impairment
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Target Recruit Count
- 16
- Registration Number
- NCT06671444
- Locations
- 🇨🇳
Zhongda Hospital Southeast University, Nanjing, Jiangsu, China
🇨🇳The First Affiliated Hospital of Bengbu Medical University, Bengbu, China
🇨🇳The First Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-01-17
- Target Recruit Count
- 157
- Registration Number
- NCT06209385
- Locations
- 🇨🇳
Shanghai East Hospital, Shanghai, Shanghai, China
🇨🇳Shandong Cancer Hospital, Jinan, Shandong, China
🇨🇳The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China